This is a non-core endpoint: only basic statistics are computed.
Benign lipomatous neoplasm (controls excluding all cancers)
CD2_BENIGN_LIPOMATOUS_EXALLC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints
-
Remove individuals based on genotype QC
9431
CD2_BENIGN_LIPOMATOUS_EXALLC
Control definitions
Control exclude
C3_CANCER
Extra metadata
Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10-D36
Name in latin
Neoplasma benignum lipomatosum
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Benign lipomatous neoplasm (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Benign lipomatous neoplasm
- Benign neoplasms
- Benign neoplasms (controls excluding all cancers)
- Neoplasms
- Any event in hilmo or specialist outpatient
Narrower endpoints:
- Benign lipomatous neoplasm
- Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk (controls excluding all cancers)
- Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
- Benign lipomatous neoplasm of other sites/unspecified
- Benign lipomatous neoplasm of other sites/unspecified (controls excluding all cancers)
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 9431 | 5380 | 4051 |
| Unadjusted prevalence (%) | 2.50 | 2.55 | 2.44 |
| Mean age at first event (years) | 52.81 | 51.70 | 54.28 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_LIPOMATOUS_EXALLC – Benign lipomatous neoplasm (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Benign lipomatous neoplasm (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.